Status:

COMPLETED

Sympathetic Activity and Cardiometabolic Complications

Lead Sponsor:

University of Turin, Italy

Conditions:

Catecholamine; Overproduction

Catecholamine; Secretion

Eligibility:

All Genders

18+ years

Brief Summary

Recent studies on catecholamine physiology have shown a direct correlation with arterial hypertension, overcoming the exclusive role in the diagnosis and follow-up of chromaffin tumors. Nevertheless,...

Detailed Description

Catecholamines (noradrenaline, adrenaline and dopamine) are adaptive and maladaptive stress hormones. In the classic "fight or flight" mechanism, they activate behavioral and physiological processes ...

Eligibility Criteria

Inclusion

  • Measurement of 24h urinary metanephrines at the laboratory of "City of Health and Science" hospital in Turin between 2007 and 2015
  • Availability of contextual clinical patient data as collected in prospective registries of Piedmont region

Exclusion

  • Diagnosis of pheochromocytoma or paraganglioma (at the time of urinary metanephrines collection or within the following 5 years)
  • Diagnosis of other forms of secondary hypertension
  • Previous cardiovascular or cerebrovascular event
  • Chronic heart failure
  • eGFR \< 50 ml/min (according to CKD-EPI)
  • Liver cirrhosis
  • Acute conditions and/or hospitalization in ICU (at the time of urinary metanephrines collection)
  • Assumption of acetaminophen during the day before the 24-hour urine collection
  • Therapy with labetalol
  • Therapy with sotalol
  • Therapy with alpha-methyldopa
  • Therapy with MAO inhibitors
  • Therapy with tricyclic antidepressants
  • Therapy with buspirone
  • Therapy with phenoxybenzamine
  • Therapy with sulfasalazine
  • Therapy with L-Dopa
  • Therapy with sympathomimetic drugs or other vasopressors
  • Alcohol abuse
  • Cocaine abuse

Key Trial Info

Start Date :

September 1 2007

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 1 2020

Estimated Enrollment :

1380 Patients enrolled

Trial Details

Trial ID

NCT04495231

Start Date

September 1 2007

End Date

July 1 2020

Last Update

July 31 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Division of Endocrinology, Diabetology and Metabolism; University of Turin

Turin, Piedmont, Italy, 10126